Vyant Bio, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Warrants (Tables)

Warrants (Tables)

3 Months Ended

Mar. 31, 2017

The following table summarizes the warrant activity for the three months ended March 31, 2017 (in thousands, except exercise price):



Issued With / For	Exercise Price			Warrants Outstanding January 1, 2017	2017 Warrants Issued	2017 Warrants Exercised		Warrants Outstanding March 31, 2017
Non-Derivative Warrants:
Financing	$	10.00		243	—	—		243
Financing	15.00			361	—	—		361
Debt guarantee	15.00			109	—	—		109
2015 Offering	5.00			3,450	—	—		3,450
Total non-derivative warrants	$	6.42	C	4,163	—	—		4,163
Derivative Warrants:
2016 Offerings	2.25		A	2,870	—	(868	)	2,002
2017 Debt	2.82		B	—	443	—		443
Total derivative warrants	2.35		C	2,870	443	(868	)	2,445
Total	$	4.92	C	7,033	443	(868	)	6,608


A	These warrants are subject to fair value accounting and contain a contingent net cash settlement feature.


B	These warrants are subject to fair value accounting and contain a net settlement provision that uses the 90-trading day price of our common stock. These warrants are subject to a 20% reduction if certain financial milestones are met.


C	Weighted-average exercise prices are as of March 31, 2017.

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details